Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Wize Pharma logo — Wize Pharma, Inc. is a clinical-stage biopharmaceutical comp...

Wize Pharma

Wize Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders.

Founded 1982 Israel Israel 2 employees Post Ipo Equity Total: $7.50M Biopharma, Biotechnology +2

General Information

Company Name Wize Pharma
Founded Year 1982
Location Israel Israel +1
Employees 2
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Post Ipo Equity
Social

Get notified when Wize Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Wize Pharma

Wize Pharma is a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders. The company has in-licensed certain rights to purchase, market, sell, and distribute a formula known as LO2A, which is currently registered and marketed in Germany, Switzerland, Hungary, and the Netherlands for the treatment of Dry Eye Syndrome (DES), CCh, and Sjögren's syndrome (Sjögren's). Founded in 1982, Wize is based in Israel and recently received a $7.50M Post-IPO Equity investment on 19 February 2020. The company has completed a Phase II trial of LO2A for patients with CCh and is currently conducting a Phase IV study for LO2A for DES in patients with Sjögren's. Wize's strategy involves engaging local or multinational distributors to handle the distribution of LO2A. As a promising player in the Biopharma, Biotechnology, Health Care, and Pharmaceutical industries, Wize Pharma presents an exciting investment opportunity with its innovative approach to addressing ophthalmic disorders.

Taxonomy: biopharmaceutical, ophthalmic disorders, clinical-stage, LO2A, drug development, distribution strategy, Phase II trial, Phase IV study, Sjögren's syndrome, CCh, in-licensing, pharmaceutical company, Israel, HaMerkaz

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 19 Feb 2020

Wize Pharma Alternatives & Competitors

Wize Pharma vs
Rubius Therapeutics
Rubius Therapeutics United States

Red blood cells are no longer just for carrying oxygen. At Rubius Therapeutics, we are transforming...

IPO
18 employees
Biotechnology
Wize Pharma vs
Sixera Pharma
Sixera Pharma Sweden

Developing treatment for Netherton syndrome - a rare skin disease

1 employees
Pharmaceutical
Wize Pharma vs
Enterome
Enterome France

Delivering the promise of immunotherapy

Series Unknown
49 employees
Biopharma, Biotechnology

FAQ About Wize Pharma

Wize Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders.
Wize Pharma was founded in 1982.
Wize Pharma is headquartered in Israel.
Wize Pharma operates in the following industries: Biopharma, Biotechnology, Health Care, Pharmaceutical.
Wize Pharma has approximately 2 employees.
Wize Pharma has completed 1 funding round, raising a total of $7.50M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Wize Pharma include Rubius Therapeutics, Sixera Pharma, Enterome, NeuroSense Therapeutics, Affymax. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Wize Pharma and Rubius Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Wize Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy